Ventas, Inc. is a real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Company operates through three segments: triple-net leased properties, senior living operations and office operations. Under its triple-net leased properties segment, the Company invests in and owns seniors housing and healthcare properties throughout the United States and the United Kingdom and leases those properties to healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses. In its senior living operations segment, it invests in seniors housing communities throughout the United States and Canada and engages independent operators to manage those communities. In its office operations segment, the Company primarily acquires, owns, develops, leases and manages medical office buildings (MOBs) and life science and innovation centers throughout the United States.
Industry, Sector and Symbol:
- Sector: Finance
- Industry: Healthcare REITs
- Sub-Industry: Specialized REITs
- Symbol: NYSE:VTR
- CUSIP: 92276F10
- Web: www.ventasreit.com
Capitalization:- Market Cap: $23.52 billion
- Outstanding Shares: 356,150,000
Average Prices:- 50 Day Moving Avg: $67.37
- 200 Day Moving Avg: $66.32
- 52 Week Range: $56.20 - $73.23
P/E:- Trailing P/E Ratio: 34.55
- Foreward P/E Ratio: 34.94
- P/E Growth: 5.49
Sales & Book Value:- Annual Revenue: $3.52 billion
- Price / Sales: 6.68
- Book Value: $29.13 per share
- Price / Book: 2.27
Dividend:- Annual Dividend: $3.10
- Dividend Yield: 4.6%
Profitability:- EBIDTA: $1.88 billion
- Net Margins: 20.08%
- Return on Equity: 6.31%
- Return on Assets: 2.81%
Debt:- Debt-to-Equity Ratio: 1.14%
- Current Ratio: 1.54%
- Quick Ratio: 1.54%
Misc:- Average Volume: 1.47 million shs.
- Beta: 0.08
- Short Ratio: 4.44
Frequently Asked Questions for Ventas (NYSE:VTR)
What is Ventas' stock symbol?
Ventas trades on the New York Stock Exchange (NYSE) under the ticker symbol "VTR."
How often does Ventas pay dividends? What is the dividend yield for Ventas?
Ventas announced a quarterly dividend on Wednesday, August 30th. Stockholders of record on Tuesday, September 12th will be given a dividend of $0.775 per share on Friday, September 29th. This represents a $3.10 dividend on an annualized basis and a dividend yield of 4.69%. The ex-dividend date is Monday, September 11th. View Ventas' Dividend History.
How were Ventas' earnings last quarter?
Ventas, Inc. (NYSE:VTR) posted its earnings results on Friday, July, 28th. The company reported $1.06 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.45 by $0.61. The business had revenue of $895.49 million for the quarter, compared to analyst estimates of $890.01 million. Ventas had a net margin of 20.08% and a return on equity of 6.31%. The business's revenue was up 5.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.42 EPS. View Ventas' Earnings History.
When will Ventas make its next earnings announcement?
What guidance has Ventas issued on next quarter's earnings?
Ventas updated its FY17 earnings guidance on Friday, July, 28th. The company provided earnings per share guidance of $4.12-4.18 for the period, compared to the Thomson Reuters consensus estimate of $4.16.
Where is Ventas' stock going? Where will Ventas' stock price be in 2017?
11 brokerages have issued 12 month price objectives for Ventas' shares. Their predictions range from $55.00 to $67.00. On average, they expect Ventas' share price to reach $61.57 in the next year. View Analyst Ratings for Ventas.
Who are some of Ventas' key competitors?
Some companies that are related to Ventas include Welltower (HCN), HCP (HCP), Omega Healthcare Investors (OHI), Healthcare Trust of America (HTA), Medical Properties Trust (MPW), Healthcare Realty Trust Incorporated (HR), National Health Investors (NHI), Physicians Realty Trust (DOC), LTC Properties (LTC), Assura PLC (AGR), Universal Health Realty Income Trust (UHT), Primary Health Properties PLC (PHP), MedEquities Realty Trust (MRT), Community Healthcare Trust Incorporated (CHCT), Aviv REIT (AVIV), Care Capital Properties (CCP), CareTrust REIT (CTRE) and Global Medical REIT (GMRE).
Who are Ventas' key executives?
Ventas' management team includes the folowing people:
- Debra A. Cafaro, Chairman of the Board, Chief Executive Officer
- Robert F. Probst, Chief Financial Officer, Executive Vice President
- T. Richard Richard Riney, Executive Vice President, Chief Administrative Officer, General Counsel
- John D. Cobb, Executive Vice President, Chief Investment Officer
- Melody C. Barnes, Independent Director
- Jay M. Gellert, Independent Director
- Richard I. Gilchrist, Independent Director
- Matthew J. Lustig, Independent Director
- Roxanne M. Martino, Independent Director
Who owns Ventas stock?
Ventas' stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (14.36%), BlackRock Inc. (10.45%), State Street Corp (5.74%), FMR LLC (5.60%), APG Asset Management US Inc. (4.03%) and Northern Trust Corp (1.84%). Company insiders that own Ventas stock include Debra A Cafaro, Douglas Crocker II, Gregory R Liebbe, John D Cobb and T Richard Riney. View Institutional Ownership Trends for Ventas.
Who sold Ventas stock? Who is selling Ventas stock?
Ventas' stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Capital World Investors, Daiwa Securities Group Inc., State Street Corp, Duff & Phelps Investment Management Co., Principal Financial Group Inc., Prudential Financial Inc. and Resolution Capital Ltd. View Insider Buying and Selling for Ventas.
Who bought Ventas stock? Who is buying Ventas stock?
Ventas' stock was purchased by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., American Century Companies Inc., Capital International Investors, Uniplan Investment Counsel Inc., BlackRock Inc., Balyasny Asset Management LLC, Russell Investments Group Ltd. and Lasalle Investment Management Securities LLC. View Insider Buying and Selling for Ventas.
How do I buy Ventas stock?
Shares of Ventas can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Ventas' stock price today?
One share of Ventas stock can currently be purchased for approximately $66.04.
MarketBeat Community Rating for Ventas (NYSE VTR)MarketBeat's community ratings are surveys of what our community members think about Ventas and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Ventas (NYSE:VTR) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 4 Sell Ratings, 6 Hold Ratings, 1 Buy Rating |
| Consensus Rating: | Hold (Score: 1.73) |
| Consensus Price Target: | $61.57 (6.77% downside) |
Analysts' Ratings History for Ventas (NYSE:VTR)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/22/2017 | Bank of America Corporation | Downgrade | Buy -> Neutral | | High |  |
| 9/17/2017 | KeyCorp | Reiterated Rating | Sell | $55.00 | Low | |
| 9/6/2017 | Royal Bank Of Canada | Reiterated Rating | Buy | | Low | |
| 8/29/2017 | Jefferies Group LLC | Reiterated Rating | Hold | $66.00 | Low | |
| 6/28/2017 | Mizuho | Reiterated Rating | Neutral | | Low | |
| 6/21/2017 | Mitsubishi UFJ Financial Group | Initiated Coverage | Hold | $67.00 | Low | |
| 4/12/2017 | BMO Capital Markets | Reiterated Rating | Sell | $60.00 | Low | |
| 3/21/2017 | SunTrust Banks, Inc. | Initiated Coverage | Hold | $64.00 | High | |
| 3/15/2017 | Goldman Sachs Group, Inc. (The) | Downgrade | Neutral -> Sell | $56.00 | Medium | |
| 3/3/2017 | Evercore ISI | Downgrade | Hold -> Underperform | | N/A | |
| 11/11/2016 | Hilliard Lyons | Upgrade | Underperform -> Neutral | | N/A | |
| 8/29/2016 | Argus | Reiterated Rating | Hold | | N/A | |
| 8/25/2016 | BTIG Research | Initiated Coverage | Neutral | | N/A | |
| 8/8/2016 | Citigroup Inc. | Boost Price Target | Neutral | $70.00 -> $75.00 | N/A | |
| 7/26/2016 | Raymond James Financial, Inc. | Initiated Coverage | Market Perform | | N/A | |
| 7/7/2016 | Barclays PLC | Reiterated Rating | Hold | $64.00 | N/A | |
| 5/12/2016 | Deutsche Bank AG | Boost Price Target | Hold | $56.00 -> $58.00 | N/A | |
| 3/3/2016 | Piper Jaffray Companies | Upgrade | Neutral -> Overweight | | N/A | |
| 2/16/2016 | Stifel Nicolaus | Downgrade | Buy -> Hold | | N/A | |
(Data available from 9/22/2015 forward)
Earnings History for Ventas (NYSE:VTR)Earnings History by Quarter for Ventas (NYSE VTR)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/26/2017 | | $0.44 | | | | | N/A | |
| 7/28/2017 | Q2 2017 | $0.45 | $1.06 | $890.01 million | $895.49 million | View | N/A | |
| 4/28/2017 | Q1 17 | $1.02 | $0.44 | $873.56 million | $883.44 million | View | N/A | |
| 2/10/2017 | Q416 | $1.02 | $1.03 | $843.40 million | $875.71 million | View | Listen | |
| 10/28/2016 | Q316 | $1.01 | $1.03 | $842.66 million | $867.12 million | View | Listen | |
| 7/29/2016 | Q216 | $1.04 | $1.04 | $845.40 million | $848.50 million | View | Listen | |
| 4/29/2016 | Q116 | $1.03 | $1.04 | $833.89 million | $852.30 million | View | Listen | |
| 2/12/2016 | Q415 | $1.01 | $1.03 | $810.05 million | $841.30 million | View | Listen | |
| 10/23/2015 | Q315 | $1.08 | $1.09 | $836.04 million | $827.60 million | View | Listen | |
| 7/24/2015 | Q215 | $1.16 | $1.18 | $871.22 million | $891.30 million | View | Listen | |
| 4/24/2015 | Q115 | $1.14 | $1.18 | $855.06 million | $884.02 million | View | Listen | |
| 2/13/2015 | Q414 | $1.12 | $1.15 | $783.95 million | $803.99 million | View | Listen | |
| 10/24/2014 | Q314 | $1.11 | $1.12 | $749.00 million | $779.00 million | View | Listen | |
| 8/11/2014 | Q214 | $1.09 | $1.09 | $741.08 million | $751.25 million | View | Listen | |
| 4/25/2014 | Q114 | $1.07 | $1.09 | $725.56 million | $741.50 million | View | Listen | |
| 2/14/2014 | Q413 | $1.06 | $1.06 | $706.39 million | $732.86 million | View | Listen | |
| 10/25/2013 | Q313 | $1.02 | $1.04 | $680.72 million | $712.39 million | View | Listen | |
| 7/26/2013 | Q213 | $1.01 | $1.01 | $677.71 million | $685.85 million | View | Listen | |
| 4/26/2013 | Q113 | $1.00 | $1.03 | $662.56 million | $384.87 million | View | Listen | |
| 2/15/2013 | Q412 | $0.97 | $0.99 | $644.71 million | $660.71 million | View | Listen | |
| 10/26/2012 | Q312 | $0.94 | $0.96 | $629.80 million | $641.95 million | View | N/A | |
| 7/26/2012 | | $0.91 | $0.95 | | | View | N/A | |
| 4/27/2012 | | $0.89 | $0.91 | | | View | N/A | |
| 11/4/2011 | | $0.82 | $0.88 | | | View | N/A | |
| 8/4/2011 | | $0.76 | $0.80 | | | View | N/A | |
| 5/5/2011 | | $0.74 | $0.75 | | | View | N/A | |
| 2/17/2011 | | $0.75 | $0.77 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Ventas (NYSE:VTR)2017 EPS Consensus Estimate: $4.14
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $1.01 | $1.02 | $1.02 |
| Q2 2017 | 2 | $1.04 | $1.04 | $1.04 |
| Q3 2017 | 3 | $1.04 | $1.05 | $1.05 |
| Q4 2017 | 3 | $1.03 | $1.05 | $1.04 |
(Data provided by Zacks Investment Research)
Current Dividend Information for Ventas (NYSE:VTR)| Next Dividend: | 9/29/2017 |
| Annual Dividend: | $3.10 |
| Dividend Yield: | 4.69% |
| Dividend Growth: | 2.70% (3 Year Average) |
| Payout Ratio: | 157.36% (Trailing 12 Months of Earnings)
170.33% (Based on This Year's Estimates)
164.02% (Based on Next Year's Estimates)
|
| Track Record: | 6 Years of Consecutive Dividend Growth |
Dividend History by Quarter for Ventas (NYSE VTR)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 8/30/2017 | quarterly | $0.78 | 4.53% | 9/11/2017 | 9/12/2017 | 9/29/2017 |
| 5/18/2017 | quarterly | $0.78 | 4.62% | 6/2/2017 | 6/6/2017 | 6/30/2017 |
| 2/10/2017 | quarterly | $0.78 | 5.03% | 3/3/2017 | 3/7/2017 | 3/31/2017 |
| 12/8/2016 | quarterly | $0.78 | 4.96% | 12/16/2016 | 12/20/2016 | 12/30/2016 |
| 8/29/2016 | quarterly | $0.73 | 3.99% | 9/13/2016 | 9/15/2016 | 9/30/2016 |
| 5/11/2016 | quarterly | $0.73 | 4.45% | 6/2/2016 | 6/6/2016 | 6/30/2016 |
| 2/12/2016 | quarterly | $0.73 | 5.87% | 3/3/2016 | 3/7/2016 | 3/31/2016 |
| 12/11/2015 | quarterly | $0.73 | 5.36% | 12/17/2015 | 12/21/2015 | 12/30/2015 |
| 9/3/2015 | quarterly | $0.73 | 5.36% | 9/11/2015 | 9/15/2015 | 9/30/2015 |
| 5/14/2015 | quarterly | $0.79 | | 6/3/2015 | 6/5/2015 | 6/30/2015 |
| 2/19/2015 | special | $0.58 | 4.14% | 3/4/2015 | 3/6/2015 | 3/31/2015 |
| 12/10/2014 | quarterly | $0.79 | 4.29% | 12/10/2014 | 12/22/2014 | 12/31/2014 |
| 9/2/2014 | quarterly | $0.73 | 4.39% | 9/10/2014 | 9/12/2014 | 9/30/2014 |
| 5/15/2014 | quarterly | $0.73 | 4.25% | 6/4/2014 | 6/6/2014 | 6/27/2014 |
| 2/14/2014 | quarterly | $0.73 | 4.72% | 3/5/2014 | 3/7/2014 | 3/28/2014 |
| 12/9/2013 | quarterly | $0.73 | 5% | 12/12/2013 | 12/16/2013 | 12/31/2013 |
| 12/9/2013 | | $0.73 | | 12/12/2013 | 12/16/2013 | 12/31/2013 |
| 9/3/2013 | quarterly | $0.67 | 4.34% | 9/11/2013 | 9/13/2013 | 9/27/2013 |
| 5/17/2013 | quarterly | $0.67 | 3.28% | 6/3/2013 | 6/5/2013 | 6/28/2013 |
| 2/19/2013 | quarterly | $0.67 | 3.86% | 3/6/2013 | 3/8/2013 | 3/28/2013 |
| 12/6/2012 | quarterly | $0.62 | | | 12/17/2012 | 12/28/2012 |
| 12/9/2012 | quarterly | $0.62 | 3.8% | 12/13/2012 | 12/17/2012 | 12/28/2012 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Ventas (NYSE:VTR)Insider Ownership Percentage: 1.30%
Institutional Ownership Percentage: 89.17%
Insider Trades by Quarter for Ventas (NYSE:VTR)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/15/2017 | Debra A Cafaro | Chairman | Sell | 100,000 | $69.12 | $6,912,000.00 | |
| 8/19/2016 | Gregory R Liebbe | SVP | Sell | 6,943 | $73.20 | $508,227.60 | |
| 8/17/2016 | T Richard Riney | EVP | Sell | 169,450 | $72.98 | $12,366,461.00 | |
| 8/2/2016 | John D Cobb | EVP | Sell | 60,000 | $75.05 | $4,503,000.00 | |
| 3/30/2016 | Douglas Crocker II | Director | Sell | 5,940 | $62.91 | $373,685.40 | |
| 1/27/2016 | John D. Cobb | EVP | Sell | 2,700 | $55.66 | $150,282.00 | |
| 1/13/2015 | Debra A Cafaro | CEO | Sell | 7,919 | $77.00 | $609,763.00 | |
| 1/12/2015 | Debra A Cafaro | CEO | Sell | 9,848 | $77.01 | $758,394.48 | |
| 1/9/2015 | Debra A Cafaro | CEO | Sell | 10,000 | $76.17 | $761,700.00 | |
| 1/6/2015 | Debra A Cafaro | CEO | Sell | 70,193 | $75.13 | $5,273,600.09 | |
| 12/12/2014 | Debra A Cafaro | CEO | Sell | 77,659 | $75.05 | $5,828,307.95 | |
| 12/2/2014 | Debra A Cafaro | CEO | Sell | 142,854 | $72.52 | $10,359,772.08 | |
| 12/1/2014 | Debra A Cafaro | CEO | Sell | 29,872 | $72.52 | $2,166,317.44 | |
| 11/25/2014 | Debra A Cafaro | CEO | Sell | 142,854 | $70.12 | $10,016,922.48 | |
| 11/3/2014 | Debra A Cafaro | CEO | Sell | 89,246 | $68.53 | $6,116,028.38 | |
| 6/10/2014 | Ronald G Geary | Director | Sell | 3,170 | $63.97 | $202,784.90 | |
| 12/10/2013 | Douglas Crocker II | Director | Buy | 10,000 | $58.01 | $580,100.00 | |
| 11/12/2012 | T Richard Riney | EVP | Sell | 52,535 | $63.78 | $3,350,682.30 | |
(Data available from 1/1/2013 forward)
Headline Trends for Ventas (NYSE:VTR)
Latest Headlines for Ventas (NYSE:VTR)
| Source: |
|
| Date | Headline |
|---|
 | Ventas, Inc. (VTR) Stock Rating Lowered by Bank of America Corporation
www.americanbankingnews.com - September 22 at 10:44 AM |
| Ventas (VTR) vs. Global Medical REIT (GMRE) Head to Head Review
www.americanbankingnews.com - September 22 at 2:36 AM |
| Contrasting Ventas (VTR) & Its Competitors
www.americanbankingnews.com - September 21 at 8:32 PM |
 | Ventas Named to Dow Jones Sustainability North America Index; Ranked #1 Healthcare REIT by GRESB
finance.yahoo.com - September 19 at 9:29 AM |
| Ventas Named to Dow Jones Sustainability North America Index; Ranked #1 Healthcare REIT by GRESB
finance.yahoo.com - September 19 at 9:29 AM |
| Why Ventas Could Be a Gold Mine for Income Investors
finance.yahoo.com - September 18 at 7:52 AM |
| $870.19 Million in Sales Expected for Ventas, Inc. (VTR) This Quarter
www.americanbankingnews.com - September 17 at 5:06 PM |
| Ventas' (VTR) "Sell" Rating Reaffirmed at KeyCorp
www.americanbankingnews.com - September 17 at 11:08 AM |
 | Ventas Is Exiting SNFs At A Profit While Reducing Risk
seekingalpha.com - September 15 at 11:13 AM |
| Zacks: Brokerages Anticipate Ventas, Inc. (VTR) Will Announce Earnings of $1.05 Per Share
www.americanbankingnews.com - September 15 at 2:14 AM |
| 3 Reasons Why This Little-Known REIT Should Be On Your Radar
seekingalpha.com - September 13 at 4:02 PM |
| Ventas to Participate in Bank of America Merrill Lynch 2017 Global Real Estate Conference
finance.yahoo.com - September 13 at 4:02 PM |
| Ventas CEO on REIT's $2 billion investment in life scienc...
finance.yahoo.com - September 13 at 4:02 PM |
| Senior Housing: A Tale Of 3 REITIES - Seeking Alpha
seekingalpha.com - September 13 at 11:05 AM |
| The Zacks Analyst Blog Highlights: Disney, Kraft Heinz and CVS Health, Intercontinental Exchange and Ventas
finance.yahoo.com - September 13 at 11:05 AM |
 | Ventas, Inc. (VTR) Ex-Dividend Date Scheduled for September 11, 2017 - Nasdaq
www.nasdaq.com - September 8 at 10:11 AM |
| Dividend Coverage: This Healthcare REIT has a Dividend Yield of 4.50%; Will Trade Ex-Dividend on September 11, 2017
finance.yahoo.com - September 8 at 10:11 AM |
| Ventas, Inc. (VTR) Given Buy Rating at Royal Bank Of Canada
www.americanbankingnews.com - September 6 at 9:40 PM |
| 3 Reasons Why We Don't Own Ventas REIT - Seeking Alpha
seekingalpha.com - September 6 at 10:02 AM |
| Ventas, Inc. (VTR) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 6 at 2:50 AM |
| Ventas Sells 22 Kindred-Operated SNFs Out of 36 in Phase I - Nasdaq
www.nasdaq.com - September 1 at 10:59 AM |
| Ventas, Inc. (VTR) Announces $0.78 Quarterly Dividend
www.americanbankingnews.com - August 30 at 10:26 AM |
| Ventas, Inc. (VTR) Rating Reiterated by Jefferies Group LLC
www.americanbankingnews.com - August 29 at 11:46 AM |
| Critical Comparison: Care Capital Properties (CCP) and Ventas (VTR)
www.americanbankingnews.com - August 29 at 6:22 AM |
| Ventas (VTR) & Welltower (HCN) Financial Contrast
www.americanbankingnews.com - August 29 at 2:16 AM |
| LTC Properties (LTC) vs. Ventas (VTR) Head-To-Head Analysis
www.americanbankingnews.com - August 28 at 10:44 AM |
| Brokerages Expect Ventas, Inc. (VTR) to Announce $1.04 Earnings Per Share
www.americanbankingnews.com - August 27 at 12:24 PM |
| Reviewing MedEquities Realty Trust (MRT) and Ventas (VTR)
www.americanbankingnews.com - August 24 at 6:26 AM |
| Jefferies Group Weighs in on Ventas, Inc.'s FY2018 Earnings (VTR)
www.americanbankingnews.com - August 23 at 1:32 PM |
| Brokers Set Expectations for Ventas, Inc.'s FY2017 Earnings (VTR)
www.americanbankingnews.com - August 22 at 8:14 AM |
| Comparing Sabra Healthcare REIT (SBRA) & Ventas (VTR)
www.americanbankingnews.com - August 21 at 4:22 AM |
| Ventas, Inc. (VTR) Upgraded to Sell by BidaskClub
www.americanbankingnews.com - August 20 at 9:56 AM |
| Ventas' (VTR) Life Science Asset Investments to Stoke Growth
www.nasdaq.com - August 18 at 8:42 AM |
| Ventas' (VTR) Life Science Asset Investments to Stoke Growth
www.nasdaq.com - August 18 at 8:42 AM |
| Ventas' (VTR) Life Science Asset Investments to Stoke Growth
finance.yahoo.com - August 18 at 8:42 AM |
 | Debra Cafaro named to PNC board
www.bizjournals.com - August 15 at 3:47 PM |
| Aviv REIT (AVIV) vs. Ventas (VTR) Head to Head Contrast
www.americanbankingnews.com - August 15 at 12:16 PM |
| VTR Crosses Above Average Analyst Target - Nasdaq
www.nasdaq.com - August 15 at 8:10 AM |
| Ventas, Inc. (NYSE:VTR) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - August 12 at 2:56 AM |
 | Pro-Trader Daily: Earnings Review and Free Research Report: Ventas' Revenue and FFO Results Outperformed Expectations
www.finanznachrichten.de - August 12 at 2:01 AM |
| $884.37 Million in Sales Expected for Ventas, Inc. (VTR) This Quarter
www.americanbankingnews.com - August 11 at 5:30 PM |
| Ventas CEO named to PNC board of directors - Pittsburgh Business Times
www.bizjournals.com - August 11 at 3:58 PM |
| Earnings Review and Free Research Report: Ventas’ Revenue and FFO Results Outperformed Expectations
finance.yahoo.com - August 11 at 3:57 PM |
| See what the IHS Markit Score report has to say about Ventas Inc.
finance.yahoo.com - August 11 at 3:57 PM |
| PNC Appoints Debra A. Cafaro To Board Of Directors
finance.yahoo.com - August 10 at 9:26 PM |
| Zacks: Brokerages Anticipate Ventas, Inc. (VTR) to Announce $1.04 EPS
www.americanbankingnews.com - August 9 at 7:10 AM |
| Ventas Becomes Oversold (VTR) - Nasdaq
www.nasdaq.com - August 8 at 8:16 AM |
| Why AvalonBay Is Not In My 'DAVOS' Portfolio - Seeking Alpha
seekingalpha.com - August 7 at 8:30 AM |
| Q3 2017 Earnings Forecast for Ventas, Inc. Issued By SunTrust Banks (VTR)
www.americanbankingnews.com - August 2 at 7:32 AM |
| FY2017 EPS Estimates for Ventas, Inc. Lowered by SunTrust Banks (NYSE:VTR)
www.americanbankingnews.com - August 1 at 8:46 AM |
Ventas (VTR) Chart for Friday, September, 22, 2017
